Ishita Drugs & Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 444125, "name": "Ishita Drugs", "stock_name": "Ishita Drugs", "full_name": "Ishita Drugs & Industries Ltd", "name_url": "stocks-analysis/ishita-drugs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "72.90", "chg": 2.02, "chgp": "2.85%", "dir": 1, "prev_price": "70.88", "mcapval": "21.00 Cr", "mcap": "Micro Cap", "scripcode": 524400, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE806D01016", "curr_date": "Sep 04, 03:30 PM", "curr_time": "03:36 AM", "last_traded_at": "Sep 04, 03:30 PM IST", "bse_nse_vol": "1.03 k", "exc_status": "Active", "traded_date": "Sep 04, 2026", "traded_date_str": "2026 09 04", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ishita-drugs-444125-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Ishita Drugs & Industries Ltd: Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-renewed-price-attractiveness-4178364", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/IshitaDrugsIndu_valuationdot_4178364.png", "date": "2026-09-02 08:00:40", "description": "Ishita Drugs & Industries Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by a recalibration of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This development comes amid a challenging pharmaceutical sector landscape and a micro-cap status that continues to influence investor sentiment. A detailed analysis of these valuation changes against historical and peer benchmarks reveals a compelling case for investors seeking value in the Pharmaceuticals & Biotechnology space." }, { "title": "Ishita Drugs & Industries Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-renewed-price-attractiveness-4170738", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IshitaDrugsIndu_valuationdot_4170738.png", "date": "2026-08-27 08:00:34", "description": "Ishita Drugs & Industries Ltd has recently seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite a modest decline in share price and a challenging sector backdrop, the company’s improved price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers suggest a compelling entry point for investors seeking value in the pharmaceuticals and biotechnology micro-cap space." }, { "title": "Ishita Drugs & Industries Ltd: Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4158504", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IshitaDrugsIndu_valuationdot_4158504.png", "date": "2026-08-18 08:00:45", "description": "Ishita Drugs & Industries Ltd has recently undergone a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a challenging market environment and a micro-cap status. This change is underscored by a recalibration of key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the stock as a compelling consideration for investors seeking value within the Pharmaceuticals & Biotechnology sector." }, { "title": "Ishita Drugs & Industries Ltd Downgraded to Strong Sell Amidst Flat Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/ishita-drugs-industries-ltd-downgraded-to-strong-sell-amidst-flat-financials-and-bearish-technicals-4146687", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IshitaDrugsIndu_mojoScore_4146687.png", "date": "2026-08-11 08:26:01", "description": "Ishita Drugs & Industries Ltd has been downgraded from a Sell to a Strong Sell rating as of 10 August 2026, reflecting deteriorating fundamentals and technical indicators. The pharmaceutical micro-cap’s financial trend has shifted from negative to flat, valuation has moved from attractive to fair, and technical signals have turned mildly bearish. This comprehensive reassessment by MarketsMOJO underscores the challenges facing the company amid sluggish sales and subdued market performance." }, { "title": "Ishita Drugs Declines 1.20% Despite Technical Upgrade: 2 Key Valuation Shifts This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-declines-120-despite-technical-upgrade-2-key-valuation-shifts-this-week-4143693", "imagepath": "", "date": "2026-08-08 17:19:37", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>3 Aug:</strong> Technical upgrade to Sell rating announced</p>\n <p><strong>4 Aug:</strong> Stock price rises 0.87% to ₹77.78 amid upgrade optimism</p>\n <p><strong>5 Aug:</strong> Valuation grade shifts from attractive to fair</p>\n <p><strong>7 Aug:</strong> Stock closes week lower at ₹74.37 (-1.20%) despite Sensex gains</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹75.27</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹74.37</di..." }, { "title": "Ishita Drugs & Industries Ltd: Valuation Shifts Signal Changing Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-changing-price-attractiveness-4136730", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IshitaDrugsIndu_valuationdot_4136730.png", "date": "2026-08-05 08:01:18", "description": "Ishita Drugs & Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and peer comparisons, prompting investors to reassess the stock’s price attractiveness relative to its historical and sector benchmarks." }, { "title": "Ishita Drugs & Industries Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/ishita-drugs-industries-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-4135748", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/IshitaDrugsIndu_mojoScore_4135748.png", "date": "2026-08-04 08:25:32", "description": "Ishita Drugs & Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance and valuation metrics. The company’s technical outlook has improved to mildly bullish, prompting the revision, although fundamental weaknesses persist in profitability and debt servicing capacity." }, { "title": "Ishita Drugs Declines 7.90% Amid Strong Sell Downgrade and Valuation Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-declines-790-amid-strong-sell-downgrade-and-valuation-shifts-4051504", "imagepath": "", "date": "2026-06-13 13:12:44", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 June:</strong> Downgrade to Strong Sell rating amid valuation and financial concerns</p>\n <p><strong>10 June:</strong> Valuation metrics shift from fair to attractive, signalling renewed price appeal</p>\n <p><strong>12 June:</strong> Stock closes the week at ₹75.06, down 7.90% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹81.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹75.06</div><div class=\"stat-change negative\">-7.90%</div>..." }, { "title": "Ishita Drugs & Industries Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/ishita-drugs-industries-ltd-valuation-shifts-signal-renewed-price-attractiveness-4043147", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/IshitaDrugsIndu_valuationdot_4043147.png", "date": "2026-06-10 08:00:42", "description": "Ishita Drugs & Industries Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite ongoing market headwinds and a recent downgrade in its overall mojo grade to Strong Sell. This recalibration in price-to-earnings and price-to-book value metrics invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector." } ], "total": 130, "sid": "444125", "stock_news_url": "https://www.marketsmojo.com/news/ishita-drugs-industries-444125" }, "announcements": [ { "caption": "Weblink Intimation Letter To The Shareholders", "datetime": "31-Aug-2026", "details": "Company has issued letters providing a weblink of Companys website to access Annual report for Financial Year 2025-26 to those members who have not registered their email addresses.", "source": "BSE" }, { "caption": "INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION 2015", "datetime": "27-Aug-2026", "details": "The E-voting period for ensuing 33rd AGM which is to be held on 30.09.2026 will commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (05:00 p.m. IST) (Both days inclusive).", "source": "BSE" }, { "caption": "INTIMATION ABOUT THE BOOK CLOSURE FOR 33RD ANNUAL GENERAL MEETING (AGM)", "datetime": "27-Aug-2026", "details": "Register of Members and Share transfer book of the Company will remain closed from 24.09.2026 to 30.09.2026 (Both days Inclusive) for the purpose of 33rd Annual General Meeting of the Company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

3 Aug: Technical upgrade to Sell rating announced

4 Aug: Stock price rises 0.87% to ₹77.78 amid upgrade optimism

5 Aug: Valuation grade shifts from attractive to fair

7 Aug: Stock closes week lower at ₹74.37 (-1.20%) despite Sensex gains

Week Open

₹75.27

Week Close

₹74.37Read full news article

Ishita Drugs & Industries Ltd: Valuation Shifts Signal Changing Price Attractiveness

2026-08-05 08:01:18

Ishita Drugs & Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and peer comparisons, prompting investors to reassess the stock’s price attractiveness relative to its historical and sector benchmarks.

Read full news article

Ishita Drugs & Industries Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-08-04 08:25:32

Ishita Drugs & Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing challenges in financial performance and valuation metrics. The company’s technical outlook has improved to mildly bullish, prompting the revision, although fundamental weaknesses persist in profitability and debt servicing capacity.

Read full news article

Ishita Drugs Declines 7.90% Amid Strong Sell Downgrade and Valuation Shifts

2026-06-13 13:12:44

Key Events This Week

8 June: Downgrade to Strong Sell rating amid valuation and financial concerns

10 June: Valuation metrics shift from fair to attractive, signalling renewed price appeal

12 June: Stock closes the week at ₹75.06, down 7.90% for the week

Read full news article

Ishita Drugs & Industries Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-10 08:00:42

Ishita Drugs & Industries Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite ongoing market headwinds and a recent downgrade in its overall mojo grade to Strong Sell. This recalibration in price-to-earnings and price-to-book value metrics invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News